Exscientia

About Exscientia

Exscientia is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design. By fusing the power of AI with the discovery experience of seasoned drug hunters, we are the first company to automate drug design, surpassing conventional approaches.
YEAR FOUNDED:
2012
LEADERSHIP:
CEO: Andrew Hopkins
COO: Mark Swindells
CTO: Jérémy Besnard
CIO: Richard Bickerton
FOLLOW EXSCIENTIA:
Tweets by Exscientia